Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
Mutation Research
|
October 13, 1999
Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents
P B Farmer
Toxicology Letters
|
December 1, 1995
Monitoring of human exposure to carcinogens through DNA and protein adduct determination
P B Farmer
Clinical Chemistry
|
July 1, 1994
Carcinogen adducts: use in diagnosis and risk assessment
P B Farmer
Chemico-Biological Interactions
|
February 1, 1975
The effect of plasma on the reaction of cyclophosphamide with 4(-p-nitrobenzyl)-pyridine
P J Cox, P B Farmer
Journal of Medicinal Chemistry
|
November 1, 1975
Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds
P B Farmer, P J Cox
Critical Reviews in Toxicology
|
January 1, 1994
Evidence for DNA and protein binding by styrene and styrene oxide
D H Phillips, P B Farmer
Mutation Research
|
March 5, 1999
What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment
P B Farmer, D E Shuker
IARC Scientific Publications
|
January 1, 1988
Urinary excretion of 3-methyladenine in humans as a marker of nucleic acid methylation
D E Shuker, P B Farmer
Environmental Health Perspectives
|
May 1, 1996
Monitoring human exposure to 2-hydroxyethylating carcinogens
P B Farmer, R Cordero, H Autrup
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
July 30, 2013
Synthesis and analysis of DNA adducts of arylamines
A Beyerbach, P B Farmer, G Sabbioni
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
Mutation Research
|
October 13, 1999
Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents
P B Farmer
Toxicology Letters
|
December 1, 1995
Monitoring of human exposure to carcinogens through DNA and protein adduct determination
P B Farmer
Clinical Chemistry
|
July 1, 1994
Carcinogen adducts: use in diagnosis and risk assessment
P B Farmer
Chemico-Biological Interactions
|
February 1, 1975
The effect of plasma on the reaction of cyclophosphamide with 4(-p-nitrobenzyl)-pyridine
P J Cox, P B Farmer
Journal of Medicinal Chemistry
|
November 1, 1975
Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds
P B Farmer, P J Cox
Critical Reviews in Toxicology
|
January 1, 1994
Evidence for DNA and protein binding by styrene and styrene oxide
D H Phillips, P B Farmer
Mutation Research
|
March 5, 1999
What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment
P B Farmer, D E Shuker
IARC Scientific Publications
|
January 1, 1988
Urinary excretion of 3-methyladenine in humans as a marker of nucleic acid methylation
D E Shuker, P B Farmer
Environmental Health Perspectives
|
May 1, 1996
Monitoring human exposure to 2-hydroxyethylating carcinogens
P B Farmer, R Cordero, H Autrup
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
July 30, 2013
Synthesis and analysis of DNA adducts of arylamines
A Beyerbach, P B Farmer, G Sabbioni
Page
of 12